Lipidomic Profiling of Plasma Free Fatty Acids in Type-1 Diabetes Highlights Specific Changes in Lipid Metabolism
Overview
Biophysics
Cell Biology
Affiliations
Type-1 diabetes mellitus (T1DM) is associated with metabolic changes leading to alterations in glucose and lipid handling. While T1DM-associated effects on many major plasma lipids have been characterised, such effects on plasma free fatty acids (FFA) have not been fully examined. Using gas chromatography-mass spectrometry, we measured the plasma concentrations of FFA species in individuals with T1DM (n = 44) and age/sex-matched healthy controls (n = 44). Relationships between FFA species and various parameters were evaluated. Plasma concentrations of myristate (14:0), palmitoleate (16:1), palmitate (16:0), linoleate (18:2), oleate (18:1c9), cis-vaccenate (18:1c11), eicosapentaenoate (20:5), arachidonate (20:4) and docosahexanoate (22:6) were reduced in the T1DM group (p < 0.0001 for all, except p = 0.0020 for eicosapentaenoate and p = 0.0068 for arachidonate); α-linolenate (18:3) and dihomo-γ-linolenate (20:3) concentrations were unchanged. The saturated/unsaturated FFA ratio, n-3/n-6 ratio, de novo lipogenesis index (palmitate (main lipogenesis product)/linoleate (only found in diet)) and elongase index (oleate/palmitoleate) were increased in the T1DM group (p = 0.0166, p = 0.0089, p < 0.0001 and p = 0.0008 respectively). The stearoyl-CoA desaturase 1 (SCD1) index 1 (palmitoleate/palmitate) and index 2 (oleate/stearate) were reduced in T1DM (p < 0.0001 for both). The delta-(5)-desaturase (D5D) index (arachidonate/dihomo-γ-linolenate) was unchanged. Age and sex had no effect on plasma FFA concentrations in T1DM, while SCD1 index 1 was positively correlated (p = 0.098) and elongase index negatively correlated with age (p = 0.0363). HbA1c was negatively correlated with all plasma FFA concentrations measured except α-linolenate and dihomo-γ-linolenate. Correlations were observed between plasma FFA concentrations and cholesterol and HDL concentrations, but not LDL concentration or diabetes duration. Collectively, these results aid our understanding of T1DM and its effects on lipid metabolism.
Cai Y, Qi X, Zheng Y, Zhang J, Su H BMC Endocr Disord. 2024; 24(1):149.
PMID: 39135021 PMC: 11318335. DOI: 10.1186/s12902-024-01679-1.
Bikulciene I, Baleisis J, Mazgelyte E, Rudys R, Vosyliute R, Simkunaite-Rizgeliene R Lipids Health Dis. 2024; 23(1):69.
PMID: 38459494 PMC: 10921692. DOI: 10.1186/s12944-024-02067-3.
Uzelac T, Smiljanic K, Takic M, Sarac I, Oggiano G, Nikolic M Int J Mol Sci. 2024; 25(4).
PMID: 38397014 PMC: 10889162. DOI: 10.3390/ijms25042335.
The role of Zn2+ in shaping intracellular Ca2+ dynamics in the heart.
Dorward A, Stewart A, Pitt S J Gen Physiol. 2023; 155(7).
PMID: 37326614 PMC: 10276528. DOI: 10.1085/jgp.202213206.
Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges.
Gianazza E, Brioschi M, Iezzi A, Paglia G, Banfi C Int J Mol Sci. 2023; 24(4).
PMID: 36834701 PMC: 9960554. DOI: 10.3390/ijms24043291.